Dr. Mikhail is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3100 Plaza Properties Blvd
Columbus, OH 43219Phone+1 614-383-6000Fax+1 614-383-6001
Summary
- Dr. Sameh Mikhail is an oncologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center, James Cancer Hospital and Solove Research Institute, Ohio State University Hospital, and Mount Carmel. He received his medical degree from Cairo University School of Medicine and has been in practice 16 years. He also speaks multiple languages, including Arabic, French, and German. He specializes in gastrointestinal cancer and hematologic oncology and is experienced in hematologic oncology, medically underserved areas, radiation oncology, gastrointestinal oncology, and gastrointestinal / hepatic pathology.
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
- Rochester General HospitalResidency, Internal Medicine, 2007 - 2009
- Rochester General HospitalResidency, Internal Medicine, 2008
- Rochester General HospitalInternship, Internal Medicine, 2004 - 2005
- Cairo University School of MedicineClass of 2001
Certifications & Licensure
- OH State Medical License 2013 - 2026
- DC State Medical License 2009 - 2014
- NY State Medical License 2007 - 2010
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Certificate of Award for Contribution to the Advancement of Medical Education Association of Hospital Medical Educators/Association of Osteopathic Directors and Medical Educators, 2007
- Clinical Excellence Award Rochester General Hospital Internal Medicine Residency Program, 2006
- Lawrence E. Young Award for Outstanding Performance as R1 Rochester General Hospital Internal Medicine Residency Program, 2005
Publications & Presentations
PubMed
- 11 citationsPhase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer.Christina Wu, Terence M. Williams, Ryan Robb, Amy Webb, Lai Wei
Clinical Cancer Research. 2020-07-01 - 102 citationsRandomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic AdenocarcinomaAnne M. Noonan, Matthew R. Farren, Susan Geyer, Ying Huang, Sanaa Tahiri
Molecular Therapy. 2016-06-01 - 71 citationsSystemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer.Matthew R. Farren, Thomas A. Mace, Susan Geyer, Sameh Mikhail, Christina Wu
Clinical Cancer Research. 2016-05-15
Journal Articles
- Molecular Profiling of Pancreatic Cancer Patients: Initial Results from the Know Your Tumor InitiativeSameh Mikhail, Vincent J Picozzi, Clinical Cancer Research
- Liver cancer stem cells. Int J of HepatolMikhail S, He AR, Int J Hepatol, 1/1/2011
- Hepatocellular carcinoma: systemic therapies and future perspectives.Mikhail S, Cosgrove D, Zeidan A., Expert Rev Anticancer Ther., 9/9/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A mechanistic radiographic and biologic phase 2 study of sunitinib in relapsed/refractory esophageal (E) and gastroesophageal (GE) cancers.Christina Sing-Ying Wu, Sameh Mikhail, Lai Wei, Ludmila Katherine Martin, Xiaobai Li, Cynthia Dawn Timmers, James Lin Chen, Sanaa Tahiri, Alison Neal, Jon P Walker, Sa..., 2014 Gastrointestinal Cancers Symposium, San Francisco, CA, 1/15/2014
- Inferior Vena Cava Filters in Patients with CancerMikhail S, Hannan L, Allen J. Sayed A, Kessler C, Pishvaian M, Georgetown University Department of Medicine Research Day, Washington D.C., DC, 5/1/2013
- Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancerMikhail, S, Shivapurkar, N, Navarro R., Bai, W., Marshall, J., Hwang, J., Pishvaian, J, Wellstein, A, A. He, R, Georgetown University Department of Medicine Research Day, Washington D.C., DC, 5/1/2012
- Join now to see all
Lectures
- Springfield Regional Tumor BoardSpringfield, OH - 9/8/2014
- The use of CDK inhibitors in treatment of gastrointestinal tumorsCharlottesville, VA - 1/18/2012
- Anemia in the elderly. A new look at an old diseaseRochester, NY - 10/11/2011
- Join now to see all
Press Mentions
- Expert Discusses Novel Treatment Options in Multiple MyelomaDecember 4th, 2017
Professional Memberships
- Member
- International Society of Gastrointestinal OncologyMember
Other Languages
- Arabic, French, German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: